vs
MALIBU BOATS, INC.（MBUU）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是MALIBU BOATS, INC.的1.2倍（$219.9M vs $188.6M），Orthofix Medical Inc.净利率更高（-1.0% vs -1.3%，领先0.3%），Orthofix Medical Inc.同比增速更快（2.0% vs -5.8%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $8.2M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -3.7%）
马里布游艇是美国休闲游艇制造商，1982年创立于加利福尼亚州默塞德，现总部位于田纳西州洛登，在澳大利亚新南威尔士州也设有生产基地。它是全球最大的水上运动拖船制造商，产品可供休闲使用，也应用于滑水、尾波滑板等各类赛事活动。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
MBUU vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$188.6M
营收增速更快
OFIX
高出7.8%
-5.8%
净利率更高
OFIX
高出0.3%
-1.3%
自由现金流更多
OFIX
多$8.6M
$8.2M
两年增速更快
OFIX
近两年复合增速
-3.7%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $188.6M | $219.9M |
| 净利润 | $-2.5M | $-2.2M |
| 毛利率 | 13.3% | 71.1% |
| 营业利润率 | -1.9% | 0.2% |
| 净利率 | -1.3% | -1.0% |
| 营收同比 | -5.8% | 2.0% |
| 净利润同比 | -204.2% | 92.4% |
| 每股收益（稀释后） | $-0.13 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MBUUOFIX
| Q4 25 | $188.6M | $219.9M | ||
| Q3 25 | $194.7M | $205.6M | ||
| Q2 25 | $207.0M | $203.1M | ||
| Q1 25 | $228.7M | $193.6M | ||
| Q4 24 | $200.3M | $215.7M | ||
| Q3 24 | $171.6M | $196.6M | ||
| Q2 24 | $158.7M | $198.6M | ||
| Q1 24 | $203.4M | $188.6M |
净利润MBUUOFIX
| Q4 25 | $-2.5M | $-2.2M | ||
| Q3 25 | $-702.0K | $-22.8M | ||
| Q2 25 | $4.7M | $-14.1M | ||
| Q1 25 | $12.9M | $-53.1M | ||
| Q4 24 | $2.4M | $-29.1M | ||
| Q3 24 | $-5.0M | $-27.4M | ||
| Q2 24 | $-19.2M | $-33.4M | ||
| Q1 24 | $-66.8M | $-36.0M |
毛利率MBUUOFIX
| Q4 25 | 13.3% | 71.1% | ||
| Q3 25 | 14.3% | 72.2% | ||
| Q2 25 | 15.8% | 68.7% | ||
| Q1 25 | 20.0% | 62.8% | ||
| Q4 24 | 18.7% | 69.0% | ||
| Q3 24 | 16.4% | 68.7% | ||
| Q2 24 | 7.9% | 67.8% | ||
| Q1 24 | 19.8% | 67.5% |
营业利润率MBUUOFIX
| Q4 25 | -1.9% | 0.2% | ||
| Q3 25 | -0.4% | -8.3% | ||
| Q2 25 | 3.3% | -7.9% | ||
| Q1 25 | 7.6% | -25.2% | ||
| Q4 24 | 1.6% | -5.3% | ||
| Q3 24 | -3.3% | -9.6% | ||
| Q2 24 | -15.4% | -12.5% | ||
| Q1 24 | -36.8% | -15.6% |
净利率MBUUOFIX
| Q4 25 | -1.3% | -1.0% | ||
| Q3 25 | -0.4% | -11.1% | ||
| Q2 25 | 2.3% | -6.9% | ||
| Q1 25 | 5.6% | -27.4% | ||
| Q4 24 | 1.2% | -13.5% | ||
| Q3 24 | -2.9% | -13.9% | ||
| Q2 24 | -12.1% | -16.8% | ||
| Q1 24 | -32.9% | -19.1% |
每股收益（稀释后）MBUUOFIX
| Q4 25 | $-0.13 | $-0.05 | ||
| Q3 25 | $-0.04 | $-0.57 | ||
| Q2 25 | $0.23 | $-0.36 | ||
| Q1 25 | $0.66 | $-1.35 | ||
| Q4 24 | $0.12 | $-0.76 | ||
| Q3 24 | $-0.25 | $-0.71 | ||
| Q2 24 | $-0.93 | $-0.88 | ||
| Q1 24 | $-3.28 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.2M | $82.0M |
| 总债务越低越好 | $20.0M | — |
| 股东权益账面价值 | $495.0M | $450.0M |
| 总资产 | $715.7M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.04× | — |
8季度趋势，按日历期对齐
现金及短期投资MBUUOFIX
| Q4 25 | $28.2M | $82.0M | ||
| Q3 25 | $44.1M | $62.9M | ||
| Q2 25 | $37.0M | $65.6M | ||
| Q1 25 | $38.7M | $58.0M | ||
| Q4 24 | $35.1M | $83.2M | ||
| Q3 24 | $27.7M | $30.1M | ||
| Q2 24 | $26.9M | $26.4M | ||
| Q1 24 | $47.1M | $27.0M |
总债务MBUUOFIX
| Q4 25 | $20.0M | — | ||
| Q3 25 | $23.0M | $157.2M | ||
| Q2 25 | $18.0M | $157.0M | ||
| Q1 25 | $28.0M | $156.9M | ||
| Q4 24 | $23.0M | $157.0M | ||
| Q3 24 | $28.0M | $118.5M | ||
| Q2 24 | $0 | $118.0M | ||
| Q1 24 | $15.0M | $118.2M |
股东权益MBUUOFIX
| Q4 25 | $495.0M | $450.0M | ||
| Q3 25 | $516.4M | $442.5M | ||
| Q2 25 | $515.5M | $458.3M | ||
| Q1 25 | $513.0M | $458.3M | ||
| Q4 24 | $509.8M | $503.1M | ||
| Q3 24 | $517.7M | $525.9M | ||
| Q2 24 | $530.0M | $546.0M | ||
| Q1 24 | $557.2M | $570.3M |
总资产MBUUOFIX
| Q4 25 | $715.7M | $850.6M | ||
| Q3 25 | $755.6M | $832.6M | ||
| Q2 25 | $734.6M | $837.2M | ||
| Q1 25 | $758.8M | $823.1M | ||
| Q4 24 | $738.7M | $893.3M | ||
| Q3 24 | $759.1M | $867.9M | ||
| Q2 24 | $739.6M | $882.0M | ||
| Q1 24 | $797.6M | $906.0M |
负债/权益比MBUUOFIX
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | 0.36× | ||
| Q2 25 | 0.03× | 0.34× | ||
| Q1 25 | 0.05× | 0.34× | ||
| Q4 24 | 0.05× | 0.31× | ||
| Q3 24 | 0.05× | 0.23× | ||
| Q2 24 | 0.00× | 0.22× | ||
| Q1 24 | 0.03× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.6M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $8.2M | $16.8M |
| 自由现金流率自由现金流/营收 | 4.4% | 7.6% |
| 资本支出强度资本支出/营收 | 2.3% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $33.3M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流MBUUOFIX
| Q4 25 | $12.6M | $27.7M | ||
| Q3 25 | $6.5M | $12.4M | ||
| Q2 25 | $21.0M | $11.6M | ||
| Q1 25 | $15.5M | $-18.4M | ||
| Q4 24 | $28.4M | $23.7M | ||
| Q3 24 | $-8.4M | $11.7M | ||
| Q2 24 | $16.3M | $9.0M | ||
| Q1 24 | $23.5M | $-18.6M |
自由现金流MBUUOFIX
| Q4 25 | $8.2M | $16.8M | ||
| Q3 25 | $2.2M | $2.5M | ||
| Q2 25 | $14.1M | $4.5M | ||
| Q1 25 | $8.8M | $-25.1M | ||
| Q4 24 | $22.8M | $15.2M | ||
| Q3 24 | $-17.0M | $6.3M | ||
| Q2 24 | $4.5M | $-360.0K | ||
| Q1 24 | $11.5M | $-29.1M |
自由现金流率MBUUOFIX
| Q4 25 | 4.4% | 7.6% | ||
| Q3 25 | 1.1% | 1.2% | ||
| Q2 25 | 6.8% | 2.2% | ||
| Q1 25 | 3.8% | -13.0% | ||
| Q4 24 | 11.4% | 7.0% | ||
| Q3 24 | -9.9% | 3.2% | ||
| Q2 24 | 2.8% | -0.2% | ||
| Q1 24 | 5.7% | -15.4% |
资本支出强度MBUUOFIX
| Q4 25 | 2.3% | 4.9% | ||
| Q3 25 | 2.2% | 4.8% | ||
| Q2 25 | 3.4% | 3.5% | ||
| Q1 25 | 2.9% | 3.5% | ||
| Q4 24 | 2.8% | 4.0% | ||
| Q3 24 | 5.0% | 2.7% | ||
| Q2 24 | 7.5% | 4.7% | ||
| Q1 24 | 5.9% | 5.6% |
现金转化率MBUUOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.50× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 12.02× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MBUU
| Boatand Trailer Sales | $68.1M | 36% |
| Saltwater Fishing | $65.3M | 35% |
| Cobalt | $52.6M | 28% |
| Part And Other Sales | $2.6M | 1% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
